# Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies

> **NCT05385432** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University Hospital, Tours** · enrollment: 244 (estimated)

## Conditions studied

- Renal Transplant Rejection
- Induction Therapy

## Interventions

- **DRUG:** Rabbit Anti thymocyte globulin (rATG)
- **DRUG:** Basiliximab

## Key facts

- **NCT ID:** NCT05385432
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-09-12
- **Primary completion:** 2027-03-01
- **Final completion:** 2030-03-01
- **Target enrollment:** 244 (ESTIMATED)
- **Last updated:** 2023-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05385432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05385432, "Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05385432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*